27th Annual Controversies in Cardiac Arrhythmias 2017

Topics

• Evidence-based clinical studies defining the role of cardiac resynchronization therapy (CRT) for patients with persistent congestive heart failure (CHF)
• The pre-market and newly approved cardiac implantable electronic devices (CIEDs) available and the most appropriate therapy for managing patients with cardiac arrhythmias
• The risks and benefits of oral anticoagulation therapy vs. left atrial appendage (LAA) for the treatment of atrial fibrillation
• The risks and benefits of warfarin vs. newer anticoagulants including the role of antidotes, and appropriate patient selection criteria for the treatment of patients with atrial fibrillation
• Advances in heritable disorders of cardiac rhythm and the expanding role of genetic testing

Who should Attend

Internists, cardiologists, primary care physicians and other health care professionals.